Insider Transactions in Q4 2025 at Vericel Corp (VCEL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
2,500
-8.9%
|
$92,500
$37.83 P/Share
|
|
Dec 02
2025
|
Paul K Wotton |
SELL
Open market or private sale
|
Direct |
2,500
-8.17%
|
$92,500
$37.97 P/Share
|
|
Dec 02
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,652
-2.42%
|
$64,428
$39.14 P/Share
|
|
Dec 02
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,652
+2.36%
|
$29,736
$18.0 P/Share
|
|
Nov 11
2025
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,642
-14.22%
|
$105,680
$40.41 P/Share
|
|
Nov 11
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,642
+12.45%
|
$42,272
$16.66 P/Share
|
|
Nov 10
2025
|
Kevin F Mclaughlin |
SELL
Open market or private sale
|
Direct |
7,000
-31.67%
|
$266,000
$38.59 P/Share
|
|
Nov 10
2025
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+24.06%
|
$14,000
$2.63 P/Share
|
|
Nov 06
2025
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,358
-31.59%
|
$294,320
$40.47 P/Share
|
|
Nov 06
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,358
+24.01%
|
$117,728
$16.66 P/Share
|